We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$5.38M
Cap. Flow
-$5.42M
Cap. Flow %
-4.55%
Top 10 Hldgs %
36.72%
Holding
80
New
8
Increased
27
Reduced
7
Closed
11

Top Buys

1
INCY icon
Incyte
INCY
+$1.8M
2
WBA
Walgreens Boots Alliance
WBA
+$1.67M
3
BIDU icon
Baidu
BIDU
+$1.6M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.53M
5
BABA icon
Alibaba
BABA
+$1.47M

Top Sells

1
IMGN
Immunogen Inc
IMGN
+$14.8M
2
NHC icon
National Healthcare
NHC
+$2.77M
3
TAST
Carrols Restaurant Group, Inc.
TAST
+$2.76M
4
FCX icon
Freeport-McMoran
FCX
+$2.13M
5
BGC icon
BGC Group
BGC
+$1.85M

Sector Composition

1 Healthcare 42.71%
2 Industrials 9.53%
3 Technology 8.54%
4 Materials 8.18%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TALO icon
26
Talos Energy
TALO
$2.36B
$1.74M 1.46%
125,000
+55,000
+79% +$718K
INCY icon
27
Incyte
INCY
$23.3B
$1.71M 1.44%
+30,000
New +$1.8M
BIDU icon
28
Baidu
BIDU
$38.4B
$1.58M 1.33%
+15,000
New +$1.6M
FHN icon
29
First Horizon
FHN
$12.1B
$1.54M 1.29%
100,000
+50,000
+100% +$718K
RBCAA icon
30
Republic Bancorp
RBCAA
$1.81B
$1.53M 1.29%
30,000
+2,500
+9% +$126K
PAAS icon
31
Pan American Silver
PAAS
$17.7B
$1.51M 1.27%
100,000
– –
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$15.2B
$1.51M 1.26%
+12,500
New +$1.53M
CGAU
33
Centerra Gold
CGAU
$3.03B
$1.48M 1.24%
250,000
+100,000
+67% +$542K
DIT icon
34
AMCON Distributing
DIT
$66.9M
$1.47M 1.24%
12,000
– –
BABA icon
35
Alibaba
BABA
$282B
$1.45M 1.22%
+20,000
New +$1.47M
NWL icon
36
Newell Brands
NWL
$2.31B
$1.41M 1.18%
175,000
– –
PFE icon
37
Pfizer
PFE
$143B
$1.39M 1.17%
50,000
– –
B
38
Barrick Mining
B
$58.4B
$1.33M 1.12%
80,000
+30,000
+60% +$469K
XOMA
39
DELISTED
Xoma
XOMA
$1.32M 1.11%
55,000
– –
CRIS icon
40
Curis
CRIS
$9.71M
$1.3M 1.1%
6,000
+4,750
+380% +$1.02M
RVNC
41
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.23M 1.03%
250,000
+175,000
+233% +$1.04M
SABR icon
42
Sabre
SABR
$716M
$1.21M 1.02%
500,000
+200,000
+67% +$671K
AVIR icon
43
Atea Pharmaceuticals
AVIR
$377M
$1.09M 0.92%
270,000
– –
COYA icon
44
Coya Therapeutics
COYA
$108M
$992K 0.83%
100,000
– –
NKTR icon
45
Nektar Therapeutics
NKTR
$2.27B
$878K 0.74%
62,656
– –
PK icon
46
Park Hotels & Resorts
PK
$2.94B
$875K 0.73%
50,000
-10,000
-17% -$162K
HRTX icon
47
Heron Therapeutics
HRTX
$90.1M
$831K 0.7%
300,000
-25,000
-8% -$62.8K
CTSO icon
48
Cytosorbents Corp
CTSO
$23.2M
$784K 0.66%
825,000
+410,000
+99% +$399K
ACAD icon
49
Acadia Pharmaceuticals
ACAD
$4.39B
$740K 0.62%
40,000
+10,000
+33% +$248K
BATL icon
50
Battalion Oil
BATL
$34.6M
$736K 0.62%
130,000
+21,700
+20% +$151K
1
2
3 4

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q1 2024 Portfolio in Review

As of Q1 2024, CM Management held 80 positions worth $119M, down 4.3% from $124M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management withdrew a net $5.42M in Q1 2024, closing 11 positions and reducing 7 holdings. Its most notable exit was Immunogen Inc, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.

Against the trend, CM Management opened a new position in Incyte worth $1.71M.

  • CM Management's largest Q1 2024 buy was Incyte: 30,000 shares worth $1.71M.
  • CM Management added most to Walgreens Boots Alliance in Q1 2024, an estimated $1.67M increase.
  • CM Management's biggest Q1 2024 reduction was BGC Group, cutting an estimated $1.85M.
  • CM Management fully exited Immunogen Inc in Q1 2024, selling an estimated $14.8M.
  • CM Management's ten largest holdings make up 37% of its $119M portfolio in Q1 2024.
  • CM Management opened 8 new positions and closed 11 in Q1 2024.
  • CM Management's portfolio value fell 4.3% quarter-over-quarter to $119M.

Based on CM Management's 13F filing for Q1 2024, filed 14 May 2024.